Hepatitis C virus (HCV) envelope glycoproteins, E1 and E2, are involved in the first steps of virus infection. The E2 ectodomain can be produced as an isolated form (E2 661 ). However, there is some concern about its proper conformation and the role that E1 can play as a chaperone for the folding of E2. In order to verify this fact we have expressed a chimeric protein (E1tmbE2) based on the fulllength E1 sequence followed by the E2 ectodomain using the baculovirus-insect cells system. The E2 ectodomain is folded in the presence of the E1, proteolytically processed by cellular proteases and secreted to cell culture media (E2 661 p), while the E1 protein is retained into the cell due to its transmembrane sequence. The purification of E2 661 p from culture media was facilitated by a His tag introduced in its amino terminus. Both E2 661 and E2 661 p glycoproteins shared very similar structural features, monitored by spectroscopic and antigenic studies. Moreover, their functional properties, tested by means of CD81 binding, were almost indistinguishable, indicating that the E2 ectodomain constitutes an independent folding unit.
Introduction
Hepatitis C virus (HCV) is a positive sense, single-stranded RNA virus belonging to the Hepacivirus genus of the Flaviviridae family. HCV infection is a major cause of liver disease, having a high propensity for establishing a chronic infection [1] . In the search of a future first vaccine for HCV, a possible strategy is to abolish the initial steps of the HCV infection. In this regard, HCV entry is a highly orchestrated process mediated by viral envelope glycoproteins E1 and E2 and several host factors including heparan sulfate, the tetraspanin CD81, the scavenger receptor BI, the tight junction proteins claudin-1 and occludin, the Niemann-Pic C1-like 1 cholesterol absorption receptor and other factors (reviewed in [2] ) .
HCV envelope glycoproteins E1 and E2 are components of the viral spike which play an essential role in virus entry into host cells by interacting with cell surface receptors and inducing fusion between the viral and cellular membranes [3, 4] . E2 is the primary glycoprotein responsible for receptor interaction, while little is known about the exact role of E1 protein. They are type I transmembrane glycoproteins, highly glycosylated, with a large N-terminal ectodomain and a C-terminal transmembrane domain. There are reports which indicate that E1 and E2 may assist each other for correct folding in such a way that E2 assists E1 by stabilizing a semi-native conformation meanwhile E1 drives E2 towards a productive folding pathway [5] [6] [7] [8] [9] . These observations would indicate that HCV envelope glycoproteins cooperate to form a functional complex. However, E2 protein acquires a three dimensional structure compatible with a native conformation when it is expressed as an isolated form [6, 9] which can block HCV infection in vitro [10] . Moreover, recent studies 5 carried out with E2 ectodomain (residues 384-661 of the polyprotein) produced, either in insect [11] or in mammalian cells [10] , have shown that E2 can act as an independent folding unit. Structural characterization of the E2 ectodomain by means of circular dichroism [10] [11] [12] and infrared spectroscopy [12] , indicates that E2 is mainly constituted by β-sheet and non-ordered structures. Based on gene organization HCV E2 envelope glycoprotein has been classified as a class II fusion protein [13] . One feature of these polypeptides is that they fold as a heterodimer with the previous glycoprotein in the precursor polyprotein. Thus, the first protein in the tandem (E1) would act as a chaperone for the folding of the second one (E2) which is the fusion protein. However, very recently the structure of the core ectodomain of E2 bound to an antigen-binding fragment has been described [14, 15] . The structure differs clearly from the extended conformation of class II fusion proteins being organized as a compact domain composed mainly of β-strands.
The fact that E1 may have some role as a chaperone for the folding of E2 can be exploited to produce E2 ectodomain in a higher proportion. To this end, we have designed a chimeric construct in which full-length E1 sequence is followed by the E2 ectodomain (E1tmbE2 construct). The expression of this construct by using the baculovirus-insect cells system allowed the folding of the E2 ectodomain in the presence of the E1 protein, and after proteolytic processing, its secretion and purification from cell culture medium. In this paper we describe the characterization of this protein, named as E2 661 p, and compare its structural and functional properties with those of the E2 ectodomain folded in the absence of E1 (E2 661 ) [10] [11] [12] . 6 
Materials and Methods
Plasmid constructs. Construct of pAcGP67-A-E2 661 (residues 384-661) plasmid has been previously described [11] . pAcGP67-A-E1tmbE2 plasmid was constructed using pAcGP67-A-E1E2 746 plasmid as template. This plasmid comprises E1 (residues 192-383) and E2 (residues 384-746) complete sequences, and it has a His tag in the amino terminal region of E1. Two PCR reactions were carried out in parallel using the same template. For the first one we used the following primers: 5´-G CGA CAT GTC CAT CAC CAT CAC CAT CAC GAA ACC CAC GTC ACC GGG-3´ (forward), which introduces a His tag in the N-terminus of E2 ectodomain and PciI restriction site and 5´-GC GGA TCC GCG GCC GCT TCA CTC GGA CCT GTC CCT GT-3´ (reverse), which hybridizes with 3´end of E2 ectodomain. The second reaction was performed with these two primers: 5´-CAA GAT GGT AAG CGC TAT TG-3´ (forward; nucleotides 4185-4204 of pAcGP67-A plasmid), which hybridizes with GP67 sequence of the plasmid, that is located upstream E1 sequence, and 5´-A AGC TTA CAC ATG TGT TTC CGC GTC GAC GCC-3´ (reverse), which allows to introduce the first four aminoacids of E2 after E1 sequence and a PciI restriction site. These two PCR amplified fragments were digested with PciI restriction enzyme, and ligated. A second PCR reaction was carried out to amplify the cDNA ligated with border primers. Amplified cDNA was digested with adequate restriction enzymes (EcoRI/NotI) and ligated in pAcGP67-A plasmid digested with the same enzymes. HCV envelope proteins sequence corresponds to genotype 1a, strain PT. -nitrilotriacetic acid agarose chromatography, according to methods previously described for the expression and isolation of E2 661 [11] . . The secondary structure of the protein was evaluated by computer fit of the dichroism spectra according to Convex Constraint Analysis (CCA) [16] . This method relies on an algorithm that calculates the contribution of the secondary structure elements that give rise to the original spectral curve without referring to spectra from model systems.
The secondary structure was also predicted from the amino acid sequence by the GOR IV method [17] .
Fluorescence spectroscopy. Emission spectra were obtained at 25ºC using an SLM AMINCO 8000C spectrofluorimeter, fitted with a 450-W xenon arc.
Excitation and emission slit widths were set at 4 nm. The protein concentration was 0.05 mg/ml and a 0.2 x 1 cm cuvette was used. Buffer was 30 mM MOPS, pH 7.0, 100 mM NaCl. Excitation was performed at 275 or 295 nm, and the emission spectra were recorded over the range 285-450 nm. The contribution of the buffer was always subtracted. The tyrosine contribution to the emission spectra was calculated by subtracting the emission spectrum measured at λ exc = 295 nm multiplied by a factor from that measured at λ exc = 275 nm. The factor was obtained from the ratio between the fluorescence intensities measured with λ exc = 275 and λ exc = 295 nm at wavelengths above 380 nm, where there is no tyrosine contribution.
SDS-PAGE.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was performed according to Laemmli using 15% polyacrylamide gels [18] . Samples were subjected to gel electrophoresis 
Enzyme Linked Immunosorbent Assay (ELISA). 96 wells microtitre plates
(Nunc F96 maxisorp) were coated overnight at 4ºC with 100 ng/well of purified recombinant protein diluted to 1 µg/ml in PBS. Unbound antigen was discarded, and the wells were blocked with 3% non-fat dry milk in PBS for 60 min at room temperature. After washing the wells were incubated at 37ºC for 2 h with human serum. Six HCV-positive human sera and ten HCV-negative human sera were used at a dilution of 1:100-1:500. The plates were washed three times with PBS/0.05% Tween 20 and incubated at 37 ºC for 1 h with 
LEL-CD81 binding assay
A 100 µl aliquot of a 3 µg/ml solution of glutathione S-transferase (GST) fusion protein expressing the second extracellular region (EC2) of the LEL of human CD81 (GST-hLEL) [19] was used to coat each well of a Nunc F96 Maxisorp, 96 well-plate and incubated overnight at room temperature. Unbound protein was discarded, and the wells were blocked with 2% non-fat dry milk in PBS/0.05% Tween 20 for 2 h at room temperature. After washing the wells with PBS/0.05% Tween 20, 100 µl of soluble E2 protein at different concentrations (0-10 µg/ml) was incubated with bound LEL-CD81 protein at room temperature for 2 h. LEL-CD81 bound E2
protein was detected using H53 antibody followed by a HRP-conjugated goat anti-mouse IgG (Sigma) at a 1:3000 dilution for 1 h at room temperature. [12] . Following a similar procedure we have designed the chimera E1tmbE2 (Fig. 1) . After the full-length E1 sequence this polypeptide contains an N-terminal His-tagged E2 ectodomain, in order to facilitate the purification of the processed E2 661 p, that should be almost identical to the previously described E2 661 [11] .
The intra and extracellular expression of E1 and E2 proteins by Tni infected cells was evaluated using anti-E1, anti-E2 and anti-His antibodies by western blot (Fig. 2a) . The theoretical masses of E1 and E2 661 p based on the amino acid sequences are 22 and 32 kDa respectively. It can be observed that the E1tmbE2 polypeptide was proteolytically processed by cellular proteases to generate the E2 ectodomain. This domain was partially secreted to the extracellular medium, while the E1 protein was retained into the infected cells.
The secreted E2 ectodomain folded in the presence of E1 was named as E2 661 p in order to distinguish it from E2 661 , folded in the absence of E1 [11] .
Intracellular E1 and E2 fractions presented complex patterns of bands, probably due to unfolded and non-processed proteins and even proteolytically cleaved proteins with different glycosylation degrees. E2 661 p protein secreted to the extracellular medium was subsequently purified using affinity chromatography on a Ni
2+
-nitrilotriacetic acid-agarose column. The protein that elutes with 200 mM imidazole had a purity higher than 95% upon densitometry of stained SDS gels (Fig. 2b) . The purified protein was recognized by monoclonal anti-His and 13 goat anti-E2 antibodies (Fig. 2b) . Following this procedure, approximately 1 mg of E2 661 p glycoprotein was obtained from 1 L of culture media. This low yield of purification compared to that of E2 661 (5-6 mg/ L culture medium [11] ) could be due to the lower secretion levels after improper processing of the chimeric protein and/or interaction of E2 with E1 retained in the insect cells.
Biochemical characterization of E2 661 p. The Edman degradation of purified E2 661 p confirmed that the amino-terminal sequence was ETHVHHHHHH, indicating that the E1tmbE2 polypeptide was properly processed after residue 383 of E1. The sequence ETHV corresponds to residues 384-387 of E2.
SDS-PAGE of recombinant E2 661 p in the presence of reducing agents
showed a single band with a molecular mass of 48 kDa (Fig. 3a) , coincident with that of E2 661 but higher than the theoretical mass based on the amino acid sequence. Based on the fact that E2 661 can be partially deglycosilated by N-glycosydase F [11] it can be suggested that both E2 661 and E2 661 p proteins have a similar glycosylation pattern, and possibly an analogous folding process. In the absence of reducing agents, E2 661 and E2 661 p migrate in SDS-PAGE as at least four bands corresponding to monomers, dimers, trimers and tetramers (Fig. 3b) , suggesting that oligomers are constituted by disulfide bonds linked monomers. The trend in oligomer distribution is maintained in the different preparations obtained. Nevertheless, the amount of monomers observed in the case of E2 661 p is higher than in E2 661 protein (Fig. 3b) . This result could be explained because E2 661 p is more diluted in the extracellular medium and, hence, intermolecular interactions should occur with less probability. A second possible explanation could be that small conformational changes in the regions implied in oligomerization were taking 14 place when E2 is folding in the presence of E1, leading to lower interaction between monomers. If this were the case, E1 would have a chaperone-like role in the folding of E2. (Fig. 4a) . Deconvolution of these spectra using the program CCA [16] yielded the percentages of secondary structure elements showed in Table 1 . As observed, both proteins showed a very similar secondary structure pattern, with a low helical content being the β-sheet the main ordered structure. The predictive GOR IV method [17] , which is based upon the propensity of each amino acid to adopt a particular secondary structure yielded basically similar results (theoretical, Table 1 ). Also, these results agree well with the recently published structure of the core of E2 ectodomain [14, 15] . Morevover, these results show that there are no changes in terms of secondary structure when the E2 ectodomain is folded in the presence of E1.
Spectroscopic
Fluorescence emission spectrum of E2 661 p showed a maximum at 332 nm upon excitation at 275 nm, which is 2 nm lower than that exhibited by E2 661 which is centered at 334 nm (Fig. 4b) . In both cases, the difference between the fluorescence spectra obtained upon excitation at 275 and 295 nm, the latter being normalized, indicated that the contribution of tyrosine residues to the emission fluorescence upon excitation at 275 nm was very 15 low, approximately 5 % (Fig. 4b) . Thus, we can conclude that in both proteins the Trp residues are located in a very similar environment of relatively low hydrophobicity. Nevertheless, as denoted by the 2 nm shift of the maximum to lower wavelength, E2 661 p fluorophores could be located in a barely more non polar microenvironment than the E2 661 ones, as a result of a slightly more compact folding of E2 ectodomain in the presence of E1. This observation would be in accordance with the lower tendency of E2 661 p to aggregate, since a more compact conformation diminishes the surface exposition of hydrophobic domains and, thus, reduces the probability of intermolecular interactions.
Antigenic characterization of E2 661 p. A panel of six HCV-positive and ten
HCV-negative human sera was used to assess the antigenic properties of E2 661 p, following the ELISA described in Methods. E2 661 p and E2 661 proteins were able to bind to antibodies present in the six HCV-positive human sera (Fig. 5, sera 1, 2, 3 , 4, 5 and 6) at different levels, whereas they were not recognized by immunoglobulins from HCV-negative sera (Fig. 5 , sera 7-8;
only two of the ten negative sera are depicted). The reactivity pattern was very similar in both cases. However, it must be noted that the mean signal obtained with E2 661 p is about 30% lower than the observed with E2 661 . This result could indicate that the protein folded in presence of E1 has a lower exposition of its epitopes, probably as a consequence of its slightly more compact conformation.
Moreover, the reactivities of both proteins with the anti-E2
conformation-dependent H53 monoclonal antibody were almost identical ( Fig.   16 5, inset). Again, these results suggest that both E2 661 and E2 661 p possess very similar conformations.
Binding of E2 661 p to CD81-LEL. The specific interaction with the human tetraspanin CD81-LEL region has been regularly used to monitor the functional properties of HCV E2 glycoprotein [20, 21] . Using a recombinant human CD81-LEL (residues 116-202) fusion protein with GST (Glutathione S-Transferase),
an ELISA binding assay has been performed with both E2 661 and E2 661 p proteins. The results shown in Fig. 6 indicate that both recombinant glycoproteins bind to CD81-LEL in a concentration dependent manner, with almost identical reactivity. Although the interaction of CD81 is specific for E2, recent studies using E1-cysteine mutants in cell-cultured HCV (HCVcc) indicated that E1 glycoprotein has a modulating effect in the binding of E2 to CD81 [22] . However, this effect must be restricted to the context of the E1E2 heterodimer, since the isolated E2 ectodomain has the same CD81-binding capacity when it folds either independently (E2 661 ) or in the presence of E1 (E2 661 p).
To sum up, the results shown herein, carried out with isolated and soluble recombinant proteins, highlight that the presence of E1 is indeed not necessary for the correct folding of the E2 ectodomain, since E2 661 and E2 661 p presented very similar structural, antigenic and functional characteristics.
Although there are reports in the literature that also support the independent folding of E2 ectodomain, most of them are based on mammalian cell culture transient expression assays with viral and non-viral vectors. Thus, using Sindbis and vaccinia virus vectors, Michalak et al. [6] showed that the folding of E2 is independent of E1, but E2 is required for the proper folding of E1. The effect of 17 co-expression of E1 and E2 glycoproteins on each other's folding was evaluated after immunoprecipitation of the expressed proteins from different mammalian cell culture supernatants with the help of a conformation-sensitive monoclonal antibody (for E2) or by analysing intramolecular disulfide bond formation (for E1). The fact that E2 ectodomain could be expressed independently of the polyprotein and that it folds in a structure able to bind to cellular receptors [23, 24] is a further evidence of its independent folding.
One strategy to increase the quantity and even the quality of recombinant proteins using the baculovirus-insect cells system has been to co-express them with a chaperone. Thus, it has been described that co-expression of both protein disulfide isomerase and the chaperone BiP increased the solubility and secretion of immunoglobulin G from insect cell [25, 26] . The postulated chaperone-like function of E1 is not translated into higher quantity but its coexpression gives rise to a slightly more compact E2 ectodomain with a lower tendency to form disulfide-bridge oligomers. In this regard, there is some controversy with respect the functionality of the HCV envelope glycoproteins and the formation of intermolecular covalent complexes. On the one hand, in cells expressing recombinant HCV glycoproteins, E1 and E2 proteins have been shown to form both E1E2 noncovalent heterodimers and large covalent E1E2 complexes, with the latter corresponding to nonfunctional aggregates while the former representing the possible functional unit for HCV entry [27] . On the other hand, more recently it has been described by using the HCVcc system the selective incorporation into secreted virions of large E1E2 disulfide-linked complexes that maintain a native conformation as they were able to bind conformation-sensitive neutralizing antibodies [28] . Furthermore, a recombinant chimeric protein based on the E1 and E2 ectodomains (E1 341 E2 661 ) was 18 produced in the baculovirus system with native-like properties in spite of having a high tendency to self-associate by forming intermolecular disulfide bridges [29] . Then, the disulfide-bridge oligomerization of HCV envelope glycoproteins seems to be compatible with the maintenance of their native properties. The results presented in this work, although related to a processed glycoprotein (E2 661 ) instead of the E1E2 heterodimer, confirm this point of view. Moreover, the E2 ectodomain folded in the absence of E1, which can be produced with a much higher yield and with a higher degree of disulfide-linked complexes [11] , showed a 30% increased ability to bind to human antibodies, making this recombinant protein potentially suitable for developing future HCV vaccines. 
